Detailed and comprehensive quality control (QC) reviews (or data verification reviews) and editing are an integral part of the production lifecycle of a document, rather than a one-off step in the development process. Mistakes and inconsistencies in a document can call into question the validity of the content or result in an incorrect interpretation of the data.
ProPharma’s team of seasoned QC reviewers/editors provides quality review and editing services across a wide array of documents and therapeutic areas.
Quality Control Review/Editing Services
ProPharma QC reviewers/editors perform targeted or comprehensive quality control reviews of documents to ensure accuracy, integrity, and consistency of both data and messaging.
Quality control reviews and/or editorial reviews are performed on any deliverable, in any therapeutic area, using either client checklists or our internal document-specific checklists to ensure the quality and consistency both within and across documents.
Benefits of Working with Our Quality Control Review/Editing Team
GLOBAL AND EXPERIENCED
ProPharma QC reviewers/editors are located across North America, Europe, and India. They have an average of 10 years of experience spanning multiple therapy areas and domains.
FLEXIBLE AND SCALABLE
With access to a large pool of experienced resources, we are responsive to changes in workload and can scale as needed to accommodate variable client demands and volume.
COMPREHENSIVE AND THOROUGH
We perform comprehensive reviews of each document using detailed document-specific checklists to ensure quality and consistency within and across documents.
News & Insights
September 18, 2025
How to Select the "Right" CMO Partner
Learn how to select the right CMO partner for your company's needs with ProPharma's CMO Compass tool. Avoid delays and regulatory issues by following a systematic selection process.
September 17, 2025
Decoding FDA’s Recent Advertising Enforcement Actions
Key takeaways from FDA’s latest enforcement letters which mark a major shift in advertising oversight and highlight new compliance risks for Sponsors.
September 10, 2025
FDA Launches Crackdown on Deceptive Drug Advertising
FDA’s new crackdown on deceptive drug advertising reshapes pharma marketing. Discover implications for sponsors, compliance strategies, and patient trust.
News & Insights
July 8, 2025
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...
January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 21, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.
